Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 7, 2026
Feasibility study protocol for the evaluation of home blood pressure in patients receiving angiogenesis inhibitor therapy: a multicenter observational studyKaori Kitaoka, Satoshi Morimoto, Shintaro Minegishi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 3, 2025
Real-World Safety and Effectiveness of Rivaroxaban in Cancer-Associated Venous Thromboembolism (PRIMECAST) - A Prospective Multicenter StudyYuichi Tamura, Norihiro Kondo, Fumie Tsukada, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 27, 2020
Advantages and challenges for noninvasive atrial fibrillation ablationMasaaki Shoji, Koji Inaba, Jun Itami, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|January 10, 2024
A Predictive Model for Cancer-Associated Thrombosis in Japanese Cancer Patients: Findings from the J-Khorana RegistryMasaaki Shoji, Yugo Yamashita, Masanobu Ishii, et al.
JACC. Advances|July 5, 2025
Prolonged Edoxaban in Patients With Low Body Weight and Cancer-Associated Isolated Distal Deep Vein ThrombosisTomoyuki Nagai, Naohiko Nakanishi, Yugo Yamashita, et al.
Thrombosis Research|February 9, 2024
The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT studyDaisuke Sueta, Yugo Yamashita, Takeshi Morimoto, et al.
Research and Practice in Thrombosis and Haemostasis|April 14, 2025
Clinical outcomes of cancer-associated isolated distal deep vein thrombosis: a comparison between asymptomatic and symptomatic thrombosis-findings from the ONCO DVT StudyYoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 18, 2024
Impact of Anemia on Clinical Outcomes of Patients With Cancer-Associated Isolated Distal Deep Vein Thrombosis Receiving Edoxaban - Insights From the ONCO DVT StudyShinya Fujiki, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Thrombosis and Haemostasis : JTH|September 16, 2024
Utility of the modified Ottawa score for identification of more preferable candidates of extended anticoagulation therapy in cancer-associated isolated distal deep vein thrombosis: insight from the ONCO DVT StudyWei Xiong, Yugo Yamashita, Takeshi Morimoto, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 22, 2024
Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT studyRyuki Chatani, Yugo Yamashita, Takeshi Morimoto, et al.
Pageof 3